ASCENSIO MEDICAL
MEDICAL DEVICE COMMERCIALISATION · AUSTRALIA & NEW ZEALAND

Where clinical depth meets commercial discipline

We take differentiated medical technologies from first regulatory submission through to clinical adoption and commercial scale — working inside theatre, ICU, cath lab and hospital executive forums, where adoption is actually decided.

Request a meeting See capabilities
MARKET ENTRY

Regulatory pathway management, territory mapping and clinical champion engagement.

CLINICAL ADOPTION

PEC and VAC approval support, structured evaluations and in-theatre case coverage.

COMMERCIAL SCALE

Capital tender navigation, consumables growth and long-range network expansion.

WHAT WE DO

We bridge innovation and execution.

Ascensio Medical partners with global medtech OEMs, surgeons and hospital leaders to bring differentiated medical technologies into real-world clinical practice across Australia and New Zealand.

We operate where adoption is built — in theatre, ICU, cath lab and executive decision-making forums — embedding ourselves within clinical programs, procurement pathways and governance systems.

We activate. We implement. We support. We scale.

AUSTRALIAN MEDICAL DEVICE MARKET
$10B
Medical device market
5.1%
Annual growth
85%
Medical devices imported
$300B+
Public hospital funding 2026–31
CLINICAL TECHNOLOGY CAPABILITIES

High-acuity hospital environments and the technologies that shape procedural care

Cardiac Surgery & Structural Heart

  • Open-heart, structural heart and minimally invasive cardiac technologies
  • Valves, grafts, annuloplasty systems and cannulation platforms
  • Surgeon education, theatre support and staff in-servicing

Paediatric & Congenital Cardiac

  • Grafts, conduits, valves and reconstructive implant technologies
  • Solutions for complex congenital and paediatric cardiac repair
  • Procedural support and centre onboarding for low-volume, high-acuity adoption

Orthopaedics, Trauma & Navigation

  • Acute trauma fixation systems and implant technologies
  • Theatre-based navigation, alignment and procedural guidance
  • Surgeon support, case coverage and theatre team education

Interventional Cardiology & Diagnostics

  • Electrophysiology, AF ablation and catheter-based technologies
  • Enterprise ECG, stress testing, Holter and integrated cardiology platforms
  • Cath lab education, in-servicing and implementation support

Perfusion, Extracorporeal & Respiratory

  • CPB systems, oxygenators, circuits, cannulae and consumables
  • ECMO / ECLS, bronchoscopy and endobronchial intervention
  • Clinical deployment and cross-functional hospital training

AI-Enabled Diagnostics & Clinical Intelligence

  • AI-driven imaging and diagnostic platforms
  • Data-led patient identification and predictive analytics
  • Capital and software deployment across hospital and research settings
HOW WE EXECUTE

A structured approach to activation, adoption and sustainable scale

1

Market Activation

  • Territory mapping and account prioritisation
  • Clinical champion identification and engagement
  • Clinical value articulation and competitive displacement strategy
2

Hospital Deployment

  • Approval pathway support — PEC, VAC and procurement engagement
  • In-theatre, ICU and procedural case support
  • Structured evaluations, centre onboarding and utilisation ramp
3

Sustainable Conversion

  • Capital tender navigation and account development
  • Consumables growth and utilisation retention
  • Network expansion and forecasting discipline

We do not operate outside the system. We work within it — clinically, operationally and commercially.

OUR TEAM

Clinical credibility, commercial discipline, operational strategy

Dejan Toracki, Chief Executive Officer

Dejan Toracki

Chief Executive Officer

More than 20 years of leadership across medical devices, pharmaceuticals and biotechnology, including senior roles at Medtronic, Anteris Technologies and GE HealthCare. He has secured multi-million-dollar enterprise tenders and led statewide diagnostic deployments across more than 200 hospitals. MBA, University of Queensland.

Simon Shearer, Chief Operating Officer

Simon Shearer

Chief Operating Officer

A strategy and transformation leader specialising in digital infrastructure, governance frameworks and AI-enabled operating models. At Ascensio he leads the operational architecture behind structured market entry and sustained commercial performance across ANZ. MBA, University of Queensland.

Dr Charles McDonald, Chief Medical Officer

Dr Charles McDonald

Chief Medical Officer

A PhD-qualified perfusionist with more than 30 years of dedicated experience in cardiothoracic surgery, cardiopulmonary bypass and ECMO at The Prince Charles Hospital in Brisbane — one of Australia's leading cardiac centres. His expertise spans intraoperative blood conservation, extracorporeal membrane oxygenation and advanced mechanical circulatory support. He has authored more than 50 peer-reviewed publications in extracorporeal circulation and has held executive board roles within the Australian and New Zealand College of Perfusion.

Embedded clinical advisory partnerships

Ascensio engages directly with internationally recognised clinical leaders across Australia and the United States in cardiothoracic surgery, cardiology, intensive care, perfusion, orthopaedics and respiratory medicine.

For OEM partners, this means market execution shaped by real clinical insight — not borrowed authority, but embedded expertise.

CONTACT

Ready for a 30-minute call to talk through your technology and how Ascensio can get your technology registered, adopted and sold in Australia and New Zealand?

Brisbane, Australia